Categories Consumer, Earnings

J.C. Penney’s stock tanks after Q1 earnings miss estimates

J.C. Penney Company Inc. (NYSE: JCP) surpassed market estimates on revenue for the first quarter of 2019 but reported a wider-than-expected loss, sending shares tumbling 8.7% in premarket hours on Tuesday.  

Total revenues were $2.55 billion, down 4.3% compared to the year-ago quarter. Net sales fell 5.6% year-over-year to $2.43 billion.

J.C. Penney reports first quarter 2019 earnings results

Comparable sales decreased 5.5%. The exit of the major appliances and in-store furniture categories had a combined negative impact of 20 basis points to comparable sales in the quarter. During the quarter, the company saw strength in its apparel and fine jewelry categories.

Net loss widened to $154 million, or $0.48 per share, compared with $78 million, or $0.25 per share, in the prior-year period. Adjusted net loss was $147 million, or $0.46 per share.

“As our inventory rationalization effort continues, we are testing a number of strategies around optimal inventory levels and assortment choice counts with a goal of delivering an improved experience for our customers and maximizing our return on investment,” said Jill Soltau, Chief Executive Officer of J.C. Penney.

At quarter-end, inventory was $2.48 billion, down 16% versus the year-ago period. Liquidity totaled approx. $1.75 billion while cash and cash equivalents were $171 million.  

The company currently expects free cash flow to be positive for fiscal year 2019.

In a separate release, J.C. Penney announced the appointment of Shawn Gensch as Executive Vice President and Chief Customer Officer, effective June 3, reporting directly to CEO Jill Soltau.

Gensch joins J.C. Penney from Sprouts Farmers Market. He will oversee all aspects of the company’s marketing strategies and initiatives including digital, advertising, creative design and customer research.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report

Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,

J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights

The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs

Comments

  1. Pingback: esports domain
  2. Pingback: dog registry
  3. Pingback: aimbot rust
  4. Pingback: candy factory
  5. Pingback: chamy rim dips
  6. Pingback: 늑대닷컴
  7. Pingback: family ho
  8. Pingback: 늑대닷컴
  9. Pingback: joyce echols
  10. Pingback: dog probiotic
  11. Pingback: french bull
  12. Pingback: chanel bucket hat
  13. Pingback: sui
  14. Pingback: minnect expert
  15. Pingback: linh
  16. Pingback: Dog Registry
  17. Pingback: Dog Registry
  18. Pingback: Dog Registry
  19. Pingback: Dog Papers
  20. Pingback: Dog Papers
  21. Pingback: french pitbull
  22. Pingback: playnet download
Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top